Results 111 to 120 of about 146,661 (289)
Heterotypic Serologic Responses after Yellow Fever Vaccination; Detection of Persons with Past St. Louis Encephalitis or Dengue [PDF]
William L. Pond +3 more
openalex +1 more source
CRISPR‐Cas systems offer transformative genome editing capabilities for precise manipulation of cellular genes. This enables two main therapeutic avenues: ex vivo modification of patient cells for re‐transplantation or direct in vivo gene targeting via advanced delivery methods.
Bahareh Farasati Far +4 more
wiley +1 more source
Isolation and identification of the etiologic virus of dengue
Susumu Hotta
openalex +2 more sources
Molecular epidemiology and phylogenetic analysis of Dengue virus type-1 and 2 isolated in Malaysia [PDF]
Muhd Hasyim Chew +2 more
openalex +1 more source
CLEC18A is a previously poorly characterized C‐type lectin. We mapped the expression of CLEC18A to the proximal tubule of the kidney and found CLEC18A to interact with sulfated glycosaminoglycans on proteoglycans. Furthermore, we found that CLEC18A plays an important role in hindering the progression of clear cell renal cell carcinomas in humans and in
Gustav Jonsson +10 more
wiley +1 more source
Application of Immunodiffusion Methods to the Antigenic Analysis of Dengue Viruses [PDF]
A. N. Ibrahim, William McD. Hammon
openalex +1 more source
ABSTRACT Introduction Chronic kidney disease is a global public health issue, affecting approximately 10% of the world's population, and more than 3 million people living with kidney failure who are estimated to be on maintenance dialysis programs, with the majority receiving hemodialysis (HD).
I. Haddiya +5 more
wiley +1 more source
Dengue is a mosquito-borne disease caused by dengue virus (DENV) infection, which remains a major public health concern worldwide owing to the lack of specific treatments or antiviral drugs available.
Nuttapong Kaewjiw +13 more
doaj +1 more source
Seroprevalence of Acute Dengue in a Malaysian Tertiary Medical Centre [PDF]
Chuan Hun Ding +9 more
openalex +1 more source

